S&P 500   4,550.98 (+0.01%)
DOW   35,400.52 (+0.19%)
QQQ   388.95 (-0.06%)
AAPL   189.93 (+0.07%)
MSFT   381.35 (+0.72%)
META   335.53 (+0.25%)
GOOGL   136.42 (+0.01%)
AMZN   146.82 (-0.62%)
TSLA   243.58 (+3.18%)
NVDA   477.00 (-1.12%)
NIO   7.19 (+0.00%)
BABA   76.37 (-1.50%)
AMD   121.56 (-0.89%)
T   16.19 (-0.12%)
F   10.34 (+0.00%)
MU   75.08 (-3.14%)
CGC   0.53 (-3.33%)
GE   119.15 (-0.68%)
DIS   93.94 (-1.29%)
AMC   6.65 (-2.21%)
PFE   29.76 (-1.26%)
PYPL   58.26 (+3.32%)
XOM   104.56 (+0.58%)
S&P 500   4,550.98 (+0.01%)
DOW   35,400.52 (+0.19%)
QQQ   388.95 (-0.06%)
AAPL   189.93 (+0.07%)
MSFT   381.35 (+0.72%)
META   335.53 (+0.25%)
GOOGL   136.42 (+0.01%)
AMZN   146.82 (-0.62%)
TSLA   243.58 (+3.18%)
NVDA   477.00 (-1.12%)
NIO   7.19 (+0.00%)
BABA   76.37 (-1.50%)
AMD   121.56 (-0.89%)
T   16.19 (-0.12%)
F   10.34 (+0.00%)
MU   75.08 (-3.14%)
CGC   0.53 (-3.33%)
GE   119.15 (-0.68%)
DIS   93.94 (-1.29%)
AMC   6.65 (-2.21%)
PFE   29.76 (-1.26%)
PYPL   58.26 (+3.32%)
XOM   104.56 (+0.58%)
S&P 500   4,550.98 (+0.01%)
DOW   35,400.52 (+0.19%)
QQQ   388.95 (-0.06%)
AAPL   189.93 (+0.07%)
MSFT   381.35 (+0.72%)
META   335.53 (+0.25%)
GOOGL   136.42 (+0.01%)
AMZN   146.82 (-0.62%)
TSLA   243.58 (+3.18%)
NVDA   477.00 (-1.12%)
NIO   7.19 (+0.00%)
BABA   76.37 (-1.50%)
AMD   121.56 (-0.89%)
T   16.19 (-0.12%)
F   10.34 (+0.00%)
MU   75.08 (-3.14%)
CGC   0.53 (-3.33%)
GE   119.15 (-0.68%)
DIS   93.94 (-1.29%)
AMC   6.65 (-2.21%)
PFE   29.76 (-1.26%)
PYPL   58.26 (+3.32%)
XOM   104.56 (+0.58%)
S&P 500   4,550.98 (+0.01%)
DOW   35,400.52 (+0.19%)
QQQ   388.95 (-0.06%)
AAPL   189.93 (+0.07%)
MSFT   381.35 (+0.72%)
META   335.53 (+0.25%)
GOOGL   136.42 (+0.01%)
AMZN   146.82 (-0.62%)
TSLA   243.58 (+3.18%)
NVDA   477.00 (-1.12%)
NIO   7.19 (+0.00%)
BABA   76.37 (-1.50%)
AMD   121.56 (-0.89%)
T   16.19 (-0.12%)
F   10.34 (+0.00%)
MU   75.08 (-3.14%)
CGC   0.53 (-3.33%)
GE   119.15 (-0.68%)
DIS   93.94 (-1.29%)
AMC   6.65 (-2.21%)
PFE   29.76 (-1.26%)
PYPL   58.26 (+3.32%)
XOM   104.56 (+0.58%)

NovoCure (NVCR) Earnings Date, Estimates & Call Transcripts

$12.34
+0.43 (+3.61%)
(As of 01:27 PM ET)
Compare
Today's Range
$11.29
▼
$12.36
50-Day Range
$11.13
▼
$18.18
52-Week Range
$10.87
▼
$120.03
Volume
602,013 shs
Average Volume
1.39 million shs
Market Capitalization
$1.32 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$45.29
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Feb. 22Estimated
Actual EPS
(Oct. 26)
-$0.46 Beat By $0.05
Consensus EPS
(Oct. 26)
-$0.51
Read Call Transcript
Listen to Call
Latest SEC 10-Q Filing
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

NVCR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NVCR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

NovoCure Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20231$0.00$0.00$0.00 
Q2 20232($0.50)$0.01($0.25) 
Q3 20233($0.57)$0.03($0.34) 
Q4 20233($0.60)$0.05($0.34) 
FY 20239($1.67)$0.09 ($0.93)

NVCR Earnings Date and Information

NovoCure last released its earnings data on October 26th, 2023. The medical equipment provider reported ($0.46) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.51) by $0.05. The company earned $127.30 million during the quarter, compared to the consensus estimate of $128.75 million. Its quarterly revenue was down 2.8% compared to the same quarter last year. NovoCure has generated ($1.86) earnings per share over the last year (($1.86) diluted earnings per share). Earnings for NovoCure are expected to decrease in the coming year, from ($2.01) to ($2.17) per share. NovoCure has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 22nd, 2024 based off prior year's report dates.

NovoCure Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/22/2024
Estimated)		------- 
10/26/2023Q3 2023($0.51)($0.46)+$0.05($0.46)$128.75 million$127.30 million      
7/27/2023Q2 2023($0.50)($0.54)($0.04)($0.54)$124.25 million$126.05 million      
5/4/2023Q1 2023($0.36)($0.50)($0.14)($0.50)$127.93 million$122.20 million      
2/23/2023Q4 2022($0.32)($0.36)($0.04)($0.36)$127.20 million$128.43 million      
10/27/2022Q3 2022($0.30)($0.25)+$0.05($0.25)$134.83 million$131.00 million
7/28/2022Q2 2022($0.14)($0.23)($0.09)($0.23)$135.13 million$140.90 million    
4/28/2022Q1 2022($0.17)($0.04)+$0.13($0.04)$134.29 million$137.50 million      
2/24/2022Q4 2021($0.10)($0.25)($0.15)($0.25)$134.49 million$133.20 million    
10/28/2021Q3 2021($0.06)($0.13)($0.07)($0.13)$141.22 million$133.61 million    
7/29/2021Q2 2021$0.02($0.14)($0.16)($0.14)$141.50 million$133.52 million      
4/29/2021Q1 2021$0.02($0.04)($0.06)($0.04)$136.54 million$134.70 million    
2/25/2021Q4 2020$0.13$0.04($0.09)$0.04$143.49 million$144.00 million    












NovoCure Earnings - Frequently Asked Questions

When is NovoCure's earnings date?

NovoCure has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 22nd, 2024 based off last year's report dates. Learn more on NVCR's earnings history.

Did NovoCure beat their earnings estimates last quarter?

In the previous quarter, NovoCure (NASDAQ:NVCR) reported ($0.46) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.51) by $0.05. Learn more on analysts' earnings estimate vs. NVCR's actual earnings.

How can I listen to NovoCure's earnings conference call?

The conference call for NovoCure's latest earnings report can be listened to online. Listen to Conference Call

How can I read NovoCure's conference call transcript?

The conference call transcript for NovoCure's latest earnings report can be read online. Read Transcript

How can I view NovoCure's earnings report?

NovoCure's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does NovoCure generate each year?

NovoCure (NASDAQ:NVCR) has a recorded annual revenue of $537.84 million.

How much profit does NovoCure generate each year?

NovoCure (NASDAQ:NVCR) has a recorded net income of -$92.53 million. NVCR has generated -$1.86 earnings per share over the last four quarters.

What is NovoCure's EPS forecast for next year?

NovoCure's earnings are expected to decrease from ($2.01) per share to ($2.17) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:NVCR) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -